Paul L. Weinstein, MD

Stamford Health - Co-director of Cancer Risk and Prevention Program, Medical Director of Medical Oncology and Hematology, Department of Medicine, President, Hematology Oncology PC, FACP, and Medical Director of Medical Oncology and Hematology at Bennett Cancer Center

Specialty

Hematology, Medical Oncology

Medical School

Chicago Medical School

Residency

Montefiore Medical Center

Fellowship

Montefiore Medical Center

Board Certifications

  • Hematology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine
  • Medical Oncology - American Board of Internal Medicine

Locations

More about Paul L. Weinstein, MD

Biography

Dr. Paul Weinstein has spent over 40 years caring for patients with cancer and blood disorders at Stamford Health. He specializes in treating breast, lung and colon cancer.

 

Dr. Weinstein first received his training in hematology before joining the growing field of oncology. In 1986, he was awarded the Ettinger Fellowship Award from the Fairfield County Chapter American Cancer Society to study bone marrow transplants.

 

Dr. Weinstein enjoys taking care of patients and finds it rewarding to provide high-quality care. He is dedicated to his patients, partnering with them to develop personalized treatment plans. He uses all the resources available, including the numerous clinical trials and robust research at Stamford Health, to help each patient achieve his or her treatment goals.

 

As Medical Director of Medical Oncology and Hematology at Bennett Cancer Center, he leads Stamford Health medical oncologists and strives to improve the quality of cancer care. Through the center’s affiliations with the Dana Farber Brigham and Women’s Cancer Care Collaborative, he helps bring the most advanced cancer care to patients at Stamford Health.

 

As co-director of the Cancer Risk and Prevention program, he also helps patients and their families understand their genetic risks for cancer. Based on their genetic test results, he helps families develop plans to prevent cancer or detect cancer in early stages.

 

Dr. Weinstein enjoys working with all his colleagues at Stamford Health in an excellent environment where excellent people do excellent things.

Special Interests

Breast cancer

Lung cancer

Colorectal cancer

Cancer risk and prevention

Cancer genetics

Published Work

Weinstein, P.L. et al. Unusual Cardiac Reaction to Chemotherapy Following Mediastinal Irradiation in Patients with Hodgkin's Disease. Am. J. Med. 60:152. 1976.

 

Cook, J.; Friedman, M.; Weinstein, P.L. Iron Supplements: Which Patient Really Needs Iron? Patient Care. 10:72, 1976.

 

Baranetsky, N.G.; Weinstein, P.L. Partial Thromboplastin Time for Screening. Ann Int. Med. 9l:498. 1979.

 

Arlin, Zalmen A.; Ahmed, Tauseef; Mittleman, Abraham; Feldman, Eric; Mehta, Rakesh; Weinstein, Paul L.; Rieber, Egmond; Sullivan, Phyllis; and Baskind, Paul. A New Regimen of Amsacrine With High Dose Cytarabine Is Safe and Effective Therapy for Acute Leukemia. Journal of Clinical Oncology. Vol. 5, No. 3. March, 1987. pp 371 375.

 

Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng D H-F, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schulz C, Hampel H, Schluger A, Giulotto E, Zoli W, Ravaioli A, Nevanlinna H, Pyrhonen S, Rowley P, Loader S, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia JL, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo MA, Greenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH, Thomas A. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing. JAMA. 278:1242-1250. 1997.

 

Salvatore A. Del Prete, M.D., Scott P. Ryan, Judith S. Jacobson, DR.PH, Robert B. Erichson, M.D., Paul L. Weinstein, M.D., and Victor R. Grann, M.D. Safety and Costs of Treating Neutropenic Fever in an Outpatient Setting. Connecticut Medicine. Volume 63, No. 12; 713:717. December 1999.

 

K.M. Steve Lo, M. Beer, A. Conkling, P. Kosonen, V.R. Grann, R.B. Erichson, P.L. Weinstein, S.A. Del Prete, N.S. Cohen, D. Xistris, M.H. Bar. Paclitaxel (TXL) + Cyclophosphamide (CTX) + G-CSF and Etoposide (VP) + CTX + G-CSF are Similar in Their Ability to Mobilize Peripheral Blood Progenitor Cell (PBCS) in Patients with Breast Cancer Undergoing High Dose Chemotherapy (HDC). Blood. 1995. Vol. 86, NO 10: Suppl 1: 986a [Abstract 3934].

 

S. Ryan, S. DelPrete, P. Weinstein, R. Erichson, M. Bar, S. Lo, N. Cohen, I. Tepler: Low-Dose Vincristine-Associated Bilateral Vocal Cord Paralysis. Connecticut Medicine. October 1999. Vol. 63, NO. 10, pp. 583-584.

Affiliations

American Medical Association

American Society of Breast Disease

Academic Appointment

Associate Clinical Professor of Medicine, Columbia University College of Physicians and Surgeons

Clinical Affiliate Memorial Hospital for Cancer and Allied Diseases, Clinical Affiliate Memorial Sloane Kettering Cancer Center

Languages

English

If you are in need of emergency care, call 911.

The majority of the physicians on the Stamford Hospital Medical Staff are not employees or agents of the Hospital. They are independent practitioners who have been granted the privilege of using the Hospital's facilities for the care and treatment of their patients. This includes, but is not limited to, emergency department physicians, anesthesiologists, radiologists, surgeons, cardiologists, obstetricians, pathologists and other consultants who may treat patients.

Insurance listings are subject to change at any time. Please verify insurance plan acceptance when scheduling an appointment with a healthcare provider.

Read important information on Non-discrimination and Interpreter Services and visit Patients Rights.